The Effect of Different Concentrations of Atropine on Myopia Prevention and Control in Adolescents

Liping LI; Hongchao ZHAO; Huiqiong ZHAO; Jun LI

doi:10.12259/j.issn.2095-610X.S20230903

Volume 44 Issue 9

Sep. 2023

Turn off MathJax

Article Contents

Abstract

References

Relative Articles

Article Navigation > Journal of Kunming Medical University > 2023 > 44(9): 80-85

Liping LI, Hongchao ZHAO, Huiqiong ZHAO, Jun LI. The Effect of Different Concentrations of Atropine on Myopia Prevention and Control in Adolescents[J]. Journal of Kunming Medical University, 2023, 44(9): 80-85. doi: 10.12259/j.issn.2095-610X.S20230903

Citation:

Liping LI, Hongchao ZHAO, Huiqiong ZHAO, Jun LI. The Effect of Different Concentrations of Atropine on Myopia Prevention and Control in Adolescents[J]. Journal of Kunming Medical University, 2023, 44(9): 80-85. doi: 10.12259/j.issn.2095-610X.S20230903

Citation:

PDF( 643 KB)

The Effect of Different Concentrations of Atropine on Myopia Prevention and Control in Adolescents

doi: 10.12259/j.issn.2095-610X.S20230903

1.
Dept. of Ophthalmology，Yuxi People’s Hospital，Yuxi Yunnan 653100
2.
Dept. of Ophthalmology，The Affiliated Hospital of Yunnan University，Kunming Yunnan 650021，China

Received Date: 2023-07-11
Available Online: 2023-09-23
Publish Date: 2023-09-30

Abstract

Abstract

Objective To investigate the effect of different concentrations of atropine on myopia prevention and control in adolescents. Methods A prospective double-blind randomized controlled trial was conducted. A total of 86 adolescent myopia patients admitted to the Department of Ophthalmology, Yuxi People’s Hospital from October 2021 to October 2022 were selected and divided into three groups by random number table method. Among them, 26 cases only wore the proper framework of single focal lens. Study group 1 （n = 30） and study group 2 （n = 30） were treated with 0.01% and 0.05% atropine eye drops while wearing fully corrected monocular frames, respectively. The axial length （AL）, uncorrected visual acuity （UCVA）, and refractive index of three groups before and after the treatment, and the clinical treatment effectiveness and adverse reaction rates of study 1 and study 2 groups were recorded respectively. Results Before the treatment, there were no statistically significant differences in ocular axial length, naked eye sight, diopter index comparison among the three groups（P > 0.05）; After the treatment, the axial length of study group 1 and study group 2 was shorter than that of the control group, the uncorrected visual acuity was higher than that of the control group, and the diopter was lower than that of the control group. There were statistically significant differences （P < 0.05）. The axial length of study group 1 and study group 2 was shorter than that of the control group, and the naked eye vision was higher than that of the control group. The diopter was lower than that of the control group, and there was a statistically significant difference （P < 0.05）; The treatment effectiveness rate of 96.67% （29/30） in study group 2 was higher than that of 73.33% （22/30） in study group 1, with a statistically significant difference （P < 0.05）; In terms of the incidence of adverse reactions, study group 1 was 13.33% （4/30）, and study group 2 was 6.67% （2/30）, with no statistically significant difference （P > 0.05）. Conclusion Compared with those only wearing the whole framework of single focal lens correction, the application of 0.01% and 0.05% atropine eye drops in juvenile myopia prevention and control of all have a certain therapeutic effect. Among them, 0.05% atropine application is more effective and it can effectively shorten the ocular axial length and improve the naked eye sight so as to reduce the diopter and incidence of adverse reactions and effectively improve the clinical treatment.
- Juvenile myopia,
- Atropine,
- Axial length,
- Uncorrected visual acuity,
- Diopter,
- Response rate of treatment

FullText(HTML)

References(18)

References

[1]	许晓丽,高路,杨晨皓. 上海市闵行区青少年儿童视力发育及屈光状态流行病学调查[J]. 中国儿童保健杂志,2021,29(9):1000-1003.
[2]	Diaz-Llopis M,Pinazo-Durán M D. Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness[J]. Archivos de la Sociedad Españ ola de Oftalmología (English Edition),2018,93(4):182-185.
[3]	Wang N L,Li S M,Wei S F. The key points and difficulties in prevention of myopia in Chinese children and adolescents[J]. [Zhong Hua Yan Ke Za Zhi] Chinese Journal of Ophthalmology,2021,57(4):241-244.
[4]	袁梅娟,林泉. 角膜塑形镜控制近视性屈光参差的研究进展[J]. 国际眼科杂志,2022,22(8):1318-1322.
[5]	李丽萍,赵洪超,陈前,等. 0.01%阿托品滴眼液联合视功能训练在轻度近视患者中的疗效及对视力水平的影响[J]. 昆明医科大学学报,2021,42(6):67-71.
[6]	Zhao C,Cai C,Ding Q,et al. Efficacy and safety of atropine to control myopia progression: A systematic review and meta-analysis[J]. BMC Ophthalmology,2020,20(1):1-8. doi: 10.1186/s12886-019-1277-9
[7]	李松玉,杨迎新,杨潮,等. 不同浓度阿托品滴眼液控制儿童青少年近视进展的Meta分析[J]. 国际眼科杂志,2023,23(1):96-102.
[8]	吴雨璇,林卓玲,吴晓航,等. 光学眼科生物测量仪StarEyes900与IOLMaster500对眼球生物学测量的一致性评价[J]. 眼科学报,2022,37(2):125-130.
[9]	Ye L,Xu H,Shi Y,et al. Efficacy and safety of consecutive use of 1% and 0.01% atropine for myopia control in chinese children: The atropine for children and adolescent myopia progression study[J]. Ophthalmology and Therapy,2022,11(6):2197-2210. doi: 10.1007/s40123-022-00572-1
[10]	李媛媛,张晓峰. 青少年儿童近视形成的影响因素和治疗进展[J]. 国际眼科杂志,2018,18(12):2179-2182.
[11]	赵文辰,何鲜桂,邓俊杰. 关于儿童和青少年高度近视干预措施的争议[J]. 中华实验眼科杂志,2022,40(6):588-593.
[12]	白桂桃,胡丽婷,李慧,等. 角膜塑形镜控制青少年近视进展有效性和安全性观察[J]. 青岛大学学报(医学版),2022,58(2):221-224.
[13]	Zhu Q,Yin J,Li X,et al. Effects of long-term wear and discontinuation of orthokeratology lenses on the eyeball parameters in children with Myopia[J]. International Journal of Medical Sciences,2023,20(1):50-56. doi: 10.7150/ijms.79496
[14]	张育,舒红莉,程妮. 低浓度阿托品滴眼液联合多焦点渐变镜治疗青少年中度近视的临床效果[J]. 临床医学研究与实践,2022,7(35):29-32.
[15]	张立新,刘辉焜,朱国平,等. 不同低浓度阿托品制剂对青少年近视防控效果及安全性探析[J]. 国际医药卫生导报,2019,25(24):4002-4006.
[16]	戴荣源. 无近视儿童夜间使用0.05%阿托品滴眼液可显著降低近视发生率[J]. 中国临床药理学杂志,2023,39(7):965.
[17]	Yam J C,Zhang X J,Zhang Y,et al. Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: Continued versus washout: phase 3 report[J]. Ophthalmology,2022,129(3):308-321. doi: 10.1016/j.ophtha.2021.10.002
[18]	Zhang M,Qiu W,An M,et al. Analysis of the reports of low-concentration atropine in controlling myopia in children[J]. Journal Franç ais d'Ophtalmologie,2023,46(3):239-248.

Relative Articles(20)

Relative Articles

[1]	Ziwen YIN, Lei WANG, huidong WU, Kehong ZHAO, Yanyang WANG, Xiaomei LIU, Yonghong YANG. Caregiver Burden Characteristics and Influencing Factors in Conservative Treatment of Adolescent Idiopathic Scoliosis. Journal of Kunming Medical University, 2023, 44(4): 69-74. doi: 10.12259/j.issn.2095-610X.S20230413
[2]	Jianmei LI, Yanling JIN. Efficacy and Safety of Bortezomib，Lenalidomide Combined with Dexamethasone in the Treatment of Multiple Myeloma. Journal of Kunming Medical University, 2023, 44(6): 120-125. doi: 10.12259/j.issn.2095-610X.S20230610
[3]	Yuexin LIU, Fangdong TIAN, Xinyi LI, Gen XIONG, Xiangyu JIANG, Xian LI, Yanni LI. Determination of Scopolamine and Atropine in Blood and Urine by LC-MS / MS. Journal of Kunming Medical University, 2022, 43(9): 147-154. doi: 10.12259/j.issn.2095-610X.S20220916
[4]	Li-ping LI, Hong-chao ZHAO, Qian CHEN, Tao ZENG, Hui-qiong ZHAO, Wen-ji WANG, Na XU, Jun LI. Effect of Atropine Eye Drops Combined with Visual Function Training in Patients with Mild Myopia and Its Influence on Visual Acuity. Journal of Kunming Medical University, 2021, 42(6): 67-71. doi: 10.12259/j.issn.2095-610X.S20210615
[5]	Guang-shun LIU, Xu-dong XIANG, Zhi-yong LV, Min ZHOU, Ya-hong WANG. The Application of Atropine in General Anaesthesia of Retaining Spontaneous Breathing for Painless Fiberoptic Bronchoscopy. Journal of Kunming Medical University, 2021, 42(9): 71-75. doi: 10.12259/j.issn.2095-610X.S20210912
[6]	Bing-cheng WU, Hong-mei DAI, Qi-zhi ZHOU, Peng SUN, Lan LI, Dong-fang QI. Phakic Posterior Chamber Intraocular Lens Implantation for Moderate and High Myopia. Journal of Kunming Medical University, 2020, 41(11): 93-97. doi: 10.12259/j.issn.2095-610X.S20201116
[7]	Huang Yao , Bai Peng . . Journal of Kunming Medical University, 2019, 40(05): 80-85.
[8]	Dai Min , Kong Lei , Zhang Qing , Zheng Zhi Kun . Effect of Improved Ahmed Glaucoma Valve Implantation for Treating Traumatic Secondary Glaucoma. Journal of Kunming Medical University, 2019, 40(03): 45-48.
[9]	Kang Jian Shu , Sun Xiao Mei , Zhao Zhi Jian , Zhang Hong . . Journal of Kunming Medical University, 2018, 39(12): 74-76.
[10]	Zhang Jie Ying , Li Yue Zu , Zhou Yuan , Li Jun . . Journal of Kunming Medical University, 2018, 39(09): 62-64.
[11]	Li Li Ping . . Journal of Kunming Medical University,
[12]	Dan Ke Ji . . Journal of Kunming Medical University,
[13]	Wang Zhe Yu . . Journal of Kunming Medical University,
[14]	Ma Xuan . . Journal of Kunming Medical University,
[15]	Wu Yang . . Journal of Kunming Medical University,
[16]	Liang Gang . . Journal of Kunming Medical University,
[17]	Liang Gang . . Journal of Kunming Medical University,
[18]	Li Cong Mei . . Journal of Kunming Medical University,
[19]	Li Chong Yang . Analysis of Related Factors of Treatment and Prognosis of Osteosarcoma in Adolescence. Journal of Kunming Medical University,
[20]	. . Journal of Kunming Medical University,